Skip to main content

NIH Seeks Research Proposals for Cancer-Related Protein Biomarker Project

NEW YORK, Feb. 14 (GenomeWeb News) - The National Institutes of Health issued last week a request for research proposals focusing on identifying protein biomarkers for cancer "where etiology of the disease is attributed to infectious agents."

 

According to the NIH, it is seeking proposals that will help develop resources to identify subpopulations of patients exposed to an infectious agent who are likely to develop infection-associated cancer.

 

"Identifying these subpopulations has proven difficult," the NIH said. "Molecular markers provide a potential tool to identify the at-risk subpopulation and the presence of early stage cancers. This initiative encourages research to identify proteomic markers for risk assessment and early detection in individuals exposed to infectious agents that have been linked to cancer."

 

The NIH said that while it will fund select research projects, "because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary." The agency added that no funds have been specifically earmarked for the program, but that "awards pursuant to this funding opportunity are considered of high programmatic significance for funding consideration."

 

The National Cancer Institute and the National Institute of Dental and Craniofacial Research are the participating institutes on this funding opportunity.

 

Additional details can be found here.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.